Done loading dataset
Done loading the ontology
Done loading IC values
PMID:27040692-Chong-2016-TBCK: Scoring completed. Candidates: 162
\begin{tabular}
{\bf Class} & {\bf r-score} & {\bf Inclusion} & & {\bf Exclusion} & {\bf IC} \\
\hline \hline
Profound global developmental delay ({\tt HP:0012736}) & 0.85 & 1.0 & 0.74 & 1.0 \\
Abdominal symptom ({\tt HP:0011458}) & 0.85 & 1.0 & 0.74 & 0.67 \\
Prominent nasal bridge ({\tt HP:0000426}) & 0.85 & 1.0 & 0.74 & 1.0 \\
Abnormality of the nasal alae ({\tt HP:0000429}) & 0.85 & 1.0 & 0.74 & 0.82 \\
Abnormality of the nares ({\tt HP:0005288}) & 0.85 & 1.0 & 0.74 & 0.82 \\
Feeding difficulties ({\tt HP:0011968}) & 0.85 & 1.0 & 0.74 & 0.83 \\
Abnormality of the basal ganglia ({\tt HP:0002134}) & 0.85 & 1.0 & 0.74 & 0.69 \\
Exaggerated cupid's bow ({\tt HP:0002263}) & 0.85 & 1.0 & 0.74 & 1.0 \\
Abnormality of digestive system physiology ({\tt HP:0025032}) & 0.85 & 1.0 & 0.74 & 0.57 \\
Cerebellar vermis hypoplasia ({\tt HP:0001320}) & 0.85 & 1.0 & 0.74 & 0.95 \\
Small forehead ({\tt HP:0000350}) & 0.85 & 1.0 & 0.74 & 1.0 \\
Small basal ganglia ({\tt HP:0012697}) & 0.85 & 1.0 & 0.74 & 1.0 \\
Narrow forehead ({\tt HP:0000341}) & 0.85 & 1.0 & 0.74 & 1.0 \\
Anteverted nares ({\tt HP:0000463}) & 0.85 & 1.0 & 0.74 & 0.95 \\
Aplasia/Hypoplasia of the cerebellar vermis ({\tt HP:0006817}) & 0.85 & 1.0 & 0.74 & 0.87 \\
Abnormality of the cerebellar vermis ({\tt HP:0002334}) & 0.85 & 1.0 & 0.74 & 0.8 \\
Cerebellar malformation ({\tt HP:0002438}) & 0.85 & 1.0 & 0.74 & 0.74 \\
Highly arched eyebrow ({\tt HP:0002553}) & 0.85 & 1.0 & 0.74 & 1.0 \\
Visual impairment ({\tt HP:0000505}) & 0.77 & 0.8 & 0.74 & 0.87 \\
Abnormality of vision ({\tt HP:0000504}) & 0.77 & 0.8 & 0.74 & 0.51 \\
Abnormality of the nasal bridge ({\tt HP:0000422}) & 0.73 & 1.0 & 0.57 & 0.83 \\
Abnormal bone ossification ({\tt HP:0011849}) & 0.66 & 0.6 & 0.74 & 0.46 \\
Osteoporosis ({\tt HP:0000939}) & 0.66 & 0.6 & 0.74 & 0.92 \\
Abnormal bone structure ({\tt HP:0003330}) & 0.66 & 0.6 & 0.74 & 0.42 \\
Agenesis of corpus callosum ({\tt HP:0001274}) & 0.66 & 0.6 & 0.74 & 1.0 \\
Reduced bone mineral density ({\tt HP:0004349}) & 0.66 & 0.6 & 0.74 & 0.8 \\
Abnormality of bone mineral density ({\tt HP:0004348}) & 0.66 & 0.6 & 0.74 & 0.55 \\
Partial agenesis of the corpus callosum ({\tt HP:0001338}) & 0.66 & 0.6 & 0.74 & 1.0 \\
Aplasia/Hypoplasia of the corpus callosum ({\tt HP:0007370}) & 0.62 & 1.0 & 0.45 & 0.95 \\
Aplasia/Hypoplasia of the cerebral white matter ({\tt HP:0012429}) & 0.62 & 1.0 & 0.45 & 0.95 \\
Abnormality of the cerebral white matter ({\tt HP:0002500}) & 0.62 & 1.0 & 0.45 & 0.68 \\
Abnormal eyebrow morphology ({\tt HP:0000534}) & 0.62 & 1.0 & 0.45 & 0.73 \\
Abnormality of the cerebral subcortex ({\tt HP:0010993}) & 0.62 & 1.0 & 0.45 & 0.6 \\
Abnormality of the corpus callosum ({\tt HP:0001273}) & 0.62 & 1.0 & 0.45 & 0.83 \\
Abnormality of skin adnexa morphology ({\tt HP:0011138}) & 0.62 & 1.0 & 0.45 & 0.46 \\
Abnormality of the hair ({\tt HP:0001595}) & 0.62 & 1.0 & 0.45 & 0.53 \\
Abnormality of central nervous system electrophysiology ({\tt HP:0030178}) & 0.54 & 0.8 & 0.4 & 0.56 \\
Hypoplasia of the corpus callosum ({\tt HP:0002079}) & 0.54 & 0.8 & 0.4 & 1.0 \\
Abnormality of muscle size ({\tt HP:0030236}) & 0.54 & 0.8 & 0.4 & 0.63 \\
Areflexia ({\tt HP:0001284}) & 0.54 & 0.8 & 0.4 & 0.89 \\
Ventriculomegaly ({\tt HP:0002119}) & 0.54 & 0.8 & 0.4 & 0.81 \\
EEG abnormality ({\tt HP:0002353}) & 0.54 & 0.8 & 0.4 & 0.58 \\
Abnormality of the cerebral ventricles ({\tt HP:0002118}) & 0.54 & 0.8 & 0.4 & 0.69 \\
Cerebral white matter hypoplasia ({\tt HP:0012430}) & 0.54 & 0.8 & 0.4 & 1.0 \\
Abnormal nervous system electrophysiology ({\tt HP:0001311}) & 0.54 & 0.8 & 0.4 & 0.56 \\
Aplasia/Hypoplasia of the cerebrum ({\tt HP:0007364}) & 0.53 & 1.0 & 0.36 & 0.8 \\
Abnormal nasal morphology ({\tt HP:0005105}) & 0.53 & 1.0 & 0.36 & 0.72 \\
Abnormality of the nasal skeleton ({\tt HP:0010937}) & 0.53 & 1.0 & 0.36 & 0.92 \\
Abnormality of the nasal bone ({\tt HP:0010939}) & 0.53 & 1.0 & 0.36 & 0.95 \\
Abnormality of the external nose ({\tt HP:0010938}) & 0.53 & 1.0 & 0.36 & 0.67 \\
Abnormality of the cerebellum ({\tt HP:0001317}) & 0.53 & 1.0 & 0.36 & 0.61 \\
Abnormality of hindbrain morphology ({\tt HP:0011282}) & 0.53 & 1.0 & 0.36 & 0.6 \\
Abnormality of the metencephalon ({\tt HP:0011283}) & 0.53 & 1.0 & 0.36 & 0.6 \\
Abnormal peripheral nervous system morphology ({\tt HP:0000759}) & 0.52 & 0.4 & 0.74 & 0.51 \\
Peripheral axonal degeneration ({\tt HP:0000764}) & 0.52 & 0.4 & 0.74 & 0.82 \\
Hyperlipidemia ({\tt HP:0003077}) & 0.52 & 0.4 & 0.74 & 0.95 \\
Peripheral neuropathy ({\tt HP:0009830}) & 0.52 & 0.4 & 0.74 & 0.65 \\
Abnormality of oral mucosa ({\tt HP:0011830}) & 0.52 & 0.4 & 0.74 & 0.68 \\
Peripheral axonal neuropathy ({\tt HP:0003477}) & 0.52 & 0.4 & 0.74 & 0.92 \\
Abnormality of lipid metabolism ({\tt HP:0003119}) & 0.52 & 0.4 & 0.74 & 0.63 \\
Fasciculations ({\tt HP:0002380}) & 0.52 & 0.4 & 0.74 & 0.92 \\
Cortical visual impairment ({\tt HP:0100704}) & 0.52 & 0.4 & 0.74 & 1.0 \\
Hypertriglyceridemia ({\tt HP:0002155}) & 0.52 & 0.4 & 0.74 & 1.0 \\
Gingival overgrowth ({\tt HP:0000212}) & 0.52 & 0.4 & 0.74 & 1.0 \\
Abnormality of the gingiva ({\tt HP:0000168}) & 0.52 & 0.4 & 0.74 & 0.78 \\
Abnormality of upper lip vermillion ({\tt HP:0011339}) & 0.45 & 1.0 & 0.29 & 0.83 \\
Abnormal morphology of the ocular adnexa ({\tt HP:0030669}) & 0.45 & 1.0 & 0.29 & 0.49 \\
Abnormality of upper lip ({\tt HP:0000177}) & 0.45 & 1.0 & 0.29 & 0.69 \\
Abnormality of the nose ({\tt HP:0000366}) & 0.45 & 1.0 & 0.29 & 0.53 \\
Abnormality of muscle morphology ({\tt HP:0011805}) & 0.45 & 0.8 & 0.31 & 0.46 \\
Abnormality of skeletal muscles ({\tt HP:0040290}) & 0.43 & 0.6 & 0.34 & 0.66 \\
Skeletal muscle hypertrophy ({\tt HP:0003712}) & 0.43 & 0.6 & 0.34 & 0.78 \\
Abnormal tongue morphology ({\tt HP:0030809}) & 0.43 & 0.6 & 0.34 & 0.69 \\
Macroglossia ({\tt HP:0000158}) & 0.43 & 0.6 & 0.34 & 0.95 \\
Abnormality of the tongue ({\tt HP:0000157}) & 0.43 & 0.6 & 0.34 & 0.65 \\
Coarse facial features ({\tt HP:0000280}) & 0.43 & 0.6 & 0.34 & 1.0 \\
Focal seizures ({\tt HP:0007359}) & 0.4 & 0.4 & 0.4 & 0.69 \\
Involuntary movements ({\tt HP:0004305}) & 0.4 & 0.4 & 0.4 & 0.64 \\
Aplasia/Hypoplasia involving the central nervous system ({\tt HP:0002977}) & 0.38 & 1.0 & 0.24 & 0.65 \\
Abnormality of the periorbital region ({\tt HP:0000606}) & 0.38 & 1.0 & 0.24 & 0.65 \\
Abnormality of the forehead ({\tt HP:0000290}) & 0.38 & 1.0 & 0.24 & 0.7 \\
Abnormality of the lip ({\tt HP:0000159}) & 0.38 & 1.0 & 0.24 & 0.62 \\
Respiratory insufficiency ({\tt HP:0002093}) & 0.37 & 0.8 & 0.24 & 0.81 \\
Abnormality of the respiratory system ({\tt HP:0002086}) & 0.37 & 0.8 & 0.24 & 0.43 \\
Functional respiratory abnormality ({\tt HP:0002795}) & 0.37 & 0.8 & 0.24 & 0.56 \\
Abnormality of the oral cavity ({\tt HP:0000163}) & 0.34 & 0.6 & 0.24 & 0.44 \\
Deeply set eye ({\tt HP:0000490}) & 0.34 & 0.6 & 0.24 & 1.0 \\
Abnormality of forebrain morphology ({\tt HP:0100547}) & 0.32 & 1.0 & 0.19 & 0.49 \\
Abnormality of the cerebrum ({\tt HP:0002060}) & 0.32 & 1.0 & 0.19 & 0.51 \\
11 pairs of ribs ({\tt HP:0000878}) & 0.31 & 0.2 & 0.74 & 1.0 \\
Cataract ({\tt HP:0000518}) & 0.31 & 0.2 & 0.74 & 0.68 \\
Abnormality of the lens ({\tt HP:0000517}) & 0.31 & 0.2 & 0.74 & 0.64 \\
Optic atrophy ({\tt HP:0000648}) & 0.31 & 0.2 & 0.74 & 1.0 \\
Muscle fibrillation ({\tt HP:0010546}) & 0.31 & 0.2 & 0.74 & 0.92 \\
Periauricular skin pits ({\tt HP:0100277}) & 0.31 & 0.2 & 0.74 & 0.92 \\
Skin pit ({\tt HP:0100276}) & 0.31 & 0.2 & 0.74 & 0.81 \\
Ptosis ({\tt HP:0000508}) & 0.31 & 0.2 & 0.74 & 0.89 \\
Abnormal aortic arch morphology ({\tt HP:0012303}) & 0.31 & 0.2 & 0.74 & 0.71 \\
Aplasia/hypoplasia affecting bones of the axial skeleton ({\tt HP:0009122}) & 0.31 & 0.2 & 0.74 & 0.64 \\
Abnormal bleeding ({\tt HP:0001892}) & 0.31 & 0.2 & 0.74 & 0.61 \\
Abnormality of the ribs ({\tt HP:0000772}) & 0.31 & 0.2 & 0.74 & 0.64 \\
Aplasia/hypoplasia involving the skeleton ({\tt HP:0009115}) & 0.31 & 0.2 & 0.74 & 0.45 \\
Multifocal epileptiform discharges ({\tt HP:0010841}) & 0.31 & 0.2 & 0.74 & 0.92 \\
Missing ribs ({\tt HP:0000921}) & 0.31 & 0.2 & 0.74 & 0.95 \\
Abnormality of the cerebral vasculature ({\tt HP:0100659}) & 0.31 & 0.2 & 0.74 & 0.67 \\
Subdural hemorrhage ({\tt HP:0100309}) & 0.31 & 0.2 & 0.74 & 1.0 \\
Abnormality of sodium homeostasis ({\tt HP:0010931}) & 0.31 & 0.2 & 0.74 & 0.92 \\
Abnormality of monovalent inorganic cation homeostasis ({\tt HP:0010930}) & 0.31 & 0.2 & 0.74 & 0.87 \\
Hyponatremia ({\tt HP:0002902}) & 0.31 & 0.2 & 0.74 & 1.0 \\
Abnormal vascular morphology ({\tt HP:0025015}) & 0.31 & 0.2 & 0.74 & 0.42 \\
Stroke ({\tt HP:0001297}) & 0.31 & 0.2 & 0.74 & 0.92 \\
Abnormal morphology of the posterior segment of the globe ({\tt HP:0004329}) & 0.31 & 0.2 & 0.74 & 0.43 \\
Abnormality of ion homeostasis ({\tt HP:0003111}) & 0.31 & 0.2 & 0.74 & 0.64 \\
Aplasia/Hypoplasia involving bones of the thorax ({\tt HP:0006711}) & 0.31 & 0.2 & 0.74 & 0.75 \\
Aplasia/Hypoplasia of the ribs ({\tt HP:0006712}) & 0.31 & 0.2 & 0.74 & 0.89 \\
Epileptiform EEG discharges ({\tt HP:0011182}) & 0.31 & 0.2 & 0.74 & 0.63 \\
EEG with focal epileptiform discharges ({\tt HP:0011185}) & 0.31 & 0.2 & 0.74 & 0.67 \\
Abnormal tongue physiology ({\tt HP:0030810}) & 0.31 & 0.2 & 0.74 & 0.87 \\
Intracranial hemorrhage ({\tt HP:0002170}) & 0.31 & 0.2 & 0.74 & 0.8 \\
Abnormality of cation homeostasis ({\tt HP:0010929}) & 0.31 & 0.2 & 0.74 & 0.67 \\
Aplasia/hypoplasia of the extremities ({\tt HP:0009815}) & 0.31 & 0.2 & 0.74 & 0.47 \\
Abnormal fundus morphology ({\tt HP:0001098}) & 0.31 & 0.2 & 0.74 & 0.45 \\
Abnormal morphology of the great vessels ({\tt HP:0030962}) & 0.31 & 0.2 & 0.74 & 0.53 \\
Abnormal systemic arterial morphology ({\tt HP:0011004}) & 0.31 & 0.2 & 0.74 & 0.47 \\
Tongue fasciculations ({\tt HP:0001308}) & 0.31 & 0.2 & 0.74 & 1.0 \\
Abnormality of the rib cage ({\tt HP:0001547}) & 0.31 & 0.2 & 0.74 & 0.62 \\
Abnormality of the optic disc ({\tt HP:0012795}) & 0.31 & 0.2 & 0.74 & 0.83 \\
Abnormal branching pattern of the aortic arch ({\tt HP:0011587}) & 0.31 & 0.2 & 0.74 & 0.77 \\
Abnormal aortic morphology ({\tt HP:0001679}) & 0.31 & 0.2 & 0.74 & 0.62 \\
Abnormality of the optic nerve ({\tt HP:0000587}) & 0.31 & 0.2 & 0.74 & 0.71 \\
Right aortic arch ({\tt HP:0012020}) & 0.31 & 0.2 & 0.74 & 0.89 \\
Abnormality of cardiovascular system physiology ({\tt HP:0011025}) & 0.31 & 0.2 & 0.74 & 0.46 \\
Abnormality of blood circulation ({\tt HP:0011028}) & 0.31 & 0.2 & 0.74 & 0.66 \\
Internal hemorrhage ({\tt HP:0011029}) & 0.31 & 0.2 & 0.74 & 0.67 \\
Turricephaly ({\tt HP:0000262}) & 0.31 & 0.2 & 0.74 & 0.95 \\
Abnormality of movement ({\tt HP:0100022}) & 0.3 & 0.4 & 0.24 & 0.54 \\
Reduced tendon reflexes ({\tt HP:0001315}) & 0.23 & 0.8 & 0.14 & 0.82 \\
Hypertrichosis ({\tt HP:0000998}) & 0.22 & 0.2 & 0.24 & 0.82 \\
Abnormality of the thorax ({\tt HP:0000765}) & 0.22 & 0.2 & 0.24 & 0.52 \\
Esodeviation ({\tt HP:0020045}) & 0.22 & 0.2 & 0.24 & 0.78 \\
Esotropia ({\tt HP:0000565}) & 0.22 & 0.2 & 0.24 & 0.79 \\
Abnormality of the midface ({\tt HP:0000309}) & 0.22 & 0.2 & 0.24 & 0.71 \\
Abnormality of the lower urinary tract ({\tt HP:0010936}) & 0.22 & 0.2 & 0.24 & 0.59 \\
Abnormal anterior segment morphology ({\tt HP:0004328}) & 0.22 & 0.2 & 0.24 & 0.48 \\
Abnormality of the cheek ({\tt HP:0004426}) & 0.22 & 0.2 & 0.24 & 0.74 \\
Abnormal hair quantity ({\tt HP:0011362}) & 0.22 & 0.2 & 0.24 & 0.68 \\
Functional abnormality of the bladder ({\tt HP:0000009}) & 0.22 & 0.2 & 0.24 & 0.76 \\
Localized skin lesion ({\tt HP:0011355}) & 0.22 & 0.2 & 0.24 & 0.51 \\
Abnormality of the urinary system physiology ({\tt HP:0011277}) & 0.22 & 0.2 & 0.24 & 0.47 \\
Neurogenic bladder ({\tt HP:0000011}) & 0.22 & 0.2 & 0.24 & 1.0 \\
Abnormality of the bladder ({\tt HP:0000014}) & 0.22 & 0.2 & 0.24 & 0.66 \\
Abnormality of periauricular region ({\tt HP:0000383}) & 0.22 & 0.2 & 0.24 & 0.82 \\
Abnormality of the orbital region ({\tt HP:0000315}) & 0.22 & 1.0 & 0.12 & 0.47 \\
Abnormality of the mouth ({\tt HP:0000153}) & 0.22 & 1.0 & 0.12 & 0.41 \\
Abnormal facial shape ({\tt HP:0001999}) & 0.19 & 0.6 & 0.11 & 0.71 \\
Abnormality of globe location ({\tt HP:0100886}) & 0.19 & 0.6 & 0.11 & 0.85 \\
Developmental regression ({\tt HP:0002376}) & 0.18 & 0.8 & 0.1 & 1.0 \\
Seizures ({\tt HP:0001250}) & 0.13 & 1.0 & 0.07 & 0.62 \\
Abnormality of digestive system morphology ({\tt HP:0025033}) & 0.13 & 0.6 & 0.07 & 0.49 \\
Abnormality of central motor function ({\tt HP:0011442}) & 0.1 & 0.2 & 0.07 & 0.55 \\
Upper motor neuron dysfunction ({\tt HP:0002493}) & 0.1 & 0.2 & 0.07 & 0.66 \\
Hyperreflexia ({\tt HP:0001347}) & 0.1 & 0.2 & 0.07 & 0.81 \\
\end{tabular}
PMID:30103036-Zapata-Aldana-2019-TBCK: Scoring completed. Candidates: 96
\begin{tabular}
{\bf Class} & {\bf r-score} & {\bf Inclusion} & & {\bf Exclusion} & {\bf IC} \\
\hline \hline
Impaired social interactions ({\tt HP:0000735}) & 0.94 & 1.0 & 0.89 & 0.87 \\
Poor eye contact ({\tt HP:0000817}) & 0.94 & 1.0 & 0.89 & 1.0 \\
Respiratory failure ({\tt HP:0002878}) & 0.94 & 1.0 & 0.89 & 1.0 \\
Abnormal social behavior ({\tt HP:0012433}) & 0.94 & 1.0 & 0.89 & 0.81 \\
Long philtrum ({\tt HP:0000343}) & 0.94 & 1.0 & 0.89 & 1.0 \\
Abnormality of the philtrum ({\tt HP:0000288}) & 0.94 & 1.0 & 0.89 & 0.79 \\
Abnormality of bony orbit of skull ({\tt HP:3000030}) & 0.72 & 1.0 & 0.56 & 0.95 \\
Abnormality of mouth shape ({\tt HP:0011338}) & 0.72 & 1.0 & 0.56 & 0.82 \\
Abnormality of central motor function ({\tt HP:0011442}) & 0.72 & 1.0 & 0.56 & 0.55 \\
Autistic behavior ({\tt HP:0000729}) & 0.72 & 1.0 & 0.56 & 0.81 \\
Open mouth ({\tt HP:0000194}) & 0.72 & 1.0 & 0.56 & 1.0 \\
Upper motor neuron dysfunction ({\tt HP:0002493}) & 0.72 & 1.0 & 0.56 & 0.66 \\
Motor delay ({\tt HP:0001270}) & 0.72 & 1.0 & 0.56 & 0.92 \\
Shallow orbits ({\tt HP:0000586}) & 0.72 & 1.0 & 0.56 & 1.0 \\
Hyperreflexia ({\tt HP:0001347}) & 0.72 & 1.0 & 0.56 & 0.81 \\
Abnormal CNS myelination ({\tt HP:0011400}) & 0.64 & 0.5 & 0.89 & 0.79 \\
Abnormality of the septum pellucidum ({\tt HP:0007375}) & 0.64 & 0.5 & 0.89 & 0.92 \\
EMG: myokymic discharges ({\tt HP:0100288}) & 0.64 & 0.5 & 0.89 & 1.0 \\
Abnormal myeloid cell morphology ({\tt HP:0020047}) & 0.64 & 0.5 & 0.89 & 0.92 \\
Abnormal adipose tissue morphology ({\tt HP:0009124}) & 0.64 & 0.5 & 0.89 & 0.66 \\
Abnormal erythrocyte morphology ({\tt HP:0001877}) & 0.64 & 0.5 & 0.89 & 0.56 \\
CNS demyelination ({\tt HP:0007305}) & 0.64 & 0.5 & 0.89 & 0.89 \\
Microcytic anemia ({\tt HP:0001935}) & 0.64 & 0.5 & 0.89 & 0.95 \\
Anemia ({\tt HP:0001903}) & 0.64 & 0.5 & 0.89 & 0.66 \\
Anemia of inadequate production ({\tt HP:0010972}) & 0.64 & 0.5 & 0.89 & 0.74 \\
Status epilepticus ({\tt HP:0002133}) & 0.64 & 0.5 & 0.89 & 0.95 \\
Hypokinesia ({\tt HP:0002375}) & 0.64 & 0.5 & 0.89 & 1.0 \\
Diminished movement ({\tt HP:0002374}) & 0.64 & 0.5 & 0.89 & 0.95 \\
lipomatous tumor ({\tt HP:0012031}) & 0.64 & 0.5 & 0.89 & 0.82 \\
lipoma ({\tt HP:0012032}) & 0.64 & 0.5 & 0.89 & 0.92 \\
EMG abnormality ({\tt HP:0003457}) & 0.64 & 0.5 & 0.89 & 0.79 \\
Self-injurious behavior ({\tt HP:0100716}) & 0.64 & 0.5 & 0.89 & 0.87 \\
Abnormal emotion/affect behavior ({\tt HP:0100851}) & 0.64 & 0.5 & 0.89 & 0.73 \\
Os odontoideum ({\tt HP:0005667}) & 0.64 & 0.5 & 0.89 & 0.95 \\
Enlarged cisterna magna ({\tt HP:0002280}) & 0.64 & 0.5 & 0.89 & 1.0 \\
Neoplasm of fatty tissue ({\tt HP:0200013}) & 0.64 & 0.5 & 0.89 & 0.82 \\
Myokymia ({\tt HP:0002411}) & 0.64 & 0.5 & 0.89 & 0.92 \\
Absent septum pellucidum ({\tt HP:0001331}) & 0.64 & 0.5 & 0.89 & 1.0 \\
Abnormal myelination ({\tt HP:0012447}) & 0.64 & 0.5 & 0.89 & 0.67 \\
Abnormal erythroid lineage cell morphology ({\tt HP:0012130}) & 0.64 & 0.5 & 0.89 & 0.92 \\
Abnormality of the odontoid process ({\tt HP:0003310}) & 0.64 & 0.5 & 0.89 & 0.87 \\
Abnormal aggressive, impulsive or violent behavior ({\tt HP:0006919}) & 0.64 & 0.5 & 0.89 & 0.83 \\
Proptosis ({\tt HP:0000520}) & 0.57 & 1.0 & 0.39 & 1.0 \\
Tented upper lip vermilion ({\tt HP:0010804}) & 0.57 & 1.0 & 0.39 & 1.0 \\
Abnormality of the cerebral cortex ({\tt HP:0002538}) & 0.57 & 1.0 & 0.39 & 0.73 \\
Brachycephaly ({\tt HP:0000248}) & 0.57 & 1.0 & 0.39 & 0.95 \\
Sloping forehead ({\tt HP:0000340}) & 0.57 & 1.0 & 0.39 & 1.0 \\
Decreased head circumference ({\tt HP:0040195}) & 0.46 & 1.0 & 0.29 & 0.89 \\
Abnormality of calvarial morphology ({\tt HP:0002648}) & 0.46 & 1.0 & 0.29 & 0.67 \\
Abnormality of the calvaria ({\tt HP:0002683}) & 0.46 & 1.0 & 0.29 & 0.59 \\
Esodeviation ({\tt HP:0020045}) & 0.44 & 0.5 & 0.39 & 0.78 \\
Esotropia ({\tt HP:0000565}) & 0.44 & 0.5 & 0.39 & 0.79 \\
Muscle weakness ({\tt HP:0001324}) & 0.44 & 0.5 & 0.39 & 0.63 \\
Poor head control ({\tt HP:0002421}) & 0.44 & 0.5 & 0.39 & 1.0 \\
Abnormality of connective tissue ({\tt HP:0003549}) & 0.44 & 0.5 & 0.39 & 0.5 \\
Deeply set eye ({\tt HP:0000490}) & 0.37 & 1.0 & 0.23 & 1.0 \\
Diffuse cerebellar atrophy ({\tt HP:0100275}) & 0.31 & 0.5 & 0.23 & 1.0 \\
Diffuse cerebral atrophy ({\tt HP:0002506}) & 0.31 & 0.5 & 0.23 & 1.0 \\
Cerebellar atrophy ({\tt HP:0001272}) & 0.31 & 0.5 & 0.23 & 0.85 \\
Generalized tonic-clonic seizures ({\tt HP:0002069}) & 0.31 & 0.5 & 0.23 & 0.89 \\
Global brain atrophy ({\tt HP:0002283}) & 0.31 & 0.5 & 0.23 & 1.0 \\
Neurological speech impairment ({\tt HP:0002167}) & 0.31 & 1.0 & 0.18 & 0.72 \\
Absent speech ({\tt HP:0001344}) & 0.31 & 1.0 & 0.18 & 1.0 \\
Abnormality of globe location ({\tt HP:0100886}) & 0.25 & 1.0 & 0.14 & 0.85 \\
Respiratory insufficiency ({\tt HP:0002093}) & 0.25 & 1.0 & 0.14 & 0.81 \\
Abnormality of the respiratory system ({\tt HP:0002086}) & 0.25 & 1.0 & 0.14 & 0.43 \\
Abnormality of skull size ({\tt HP:0000240}) & 0.25 & 1.0 & 0.14 & 0.82 \\
Functional respiratory abnormality ({\tt HP:0002795}) & 0.25 & 1.0 & 0.14 & 0.56 \\
Abnormality of movement ({\tt HP:0100022}) & 0.22 & 0.5 & 0.14 & 0.54 \\
Atrophy/Degeneration affecting the cerebrum ({\tt HP:0007369}) & 0.22 & 0.5 & 0.14 & 0.78 \\
Abnormality of the vertebral column ({\tt HP:0000925}) & 0.22 & 0.5 & 0.14 & 0.46 \\
Generalized seizures ({\tt HP:0002197}) & 0.22 & 0.5 & 0.14 & 0.77 \\
Cerebral atrophy ({\tt HP:0002059}) & 0.22 & 0.5 & 0.14 & 0.82 \\
Brain very small ({\tt HP:0001322}) & 0.22 & 0.5 & 0.14 & 0.76 \\
Brain atrophy ({\tt HP:0012444}) & 0.22 & 0.5 & 0.14 & 0.76 \\
Delayed speech and language development ({\tt HP:0000750}) & 0.21 & 1.0 & 0.12 & 0.83 \\
Abnormality of upper lip vermillion ({\tt HP:0011339}) & 0.21 & 1.0 & 0.12 & 0.83 \\
Abnormality of upper lip ({\tt HP:0000177}) & 0.21 & 1.0 & 0.12 & 0.69 \\
Abnormality of digestive system morphology ({\tt HP:0025033}) & 0.21 & 1.0 & 0.12 & 0.49 \\
Abnormality of the skull ({\tt HP:0000929}) & 0.17 & 1.0 & 0.09 & 0.47 \\
Abnormality of the periorbital region ({\tt HP:0000606}) & 0.17 & 1.0 & 0.09 & 0.65 \\
Abnormality of the forehead ({\tt HP:0000290}) & 0.17 & 1.0 & 0.09 & 0.7 \\
Abnormality of the lip ({\tt HP:0000159}) & 0.17 & 1.0 & 0.09 & 0.62 \\
Abnormal conjugate eye movement ({\tt HP:0000549}) & 0.16 & 0.5 & 0.09 & 0.63 \\
Strabismus ({\tt HP:0000486}) & 0.16 & 0.5 & 0.09 & 0.64 \\
Abnormality of forebrain morphology ({\tt HP:0100547}) & 0.14 & 1.0 & 0.08 & 0.49 \\
Behavioral abnormality ({\tt HP:0000708}) & 0.14 & 1.0 & 0.08 & 0.52 \\
Abnormality of the cerebrum ({\tt HP:0002060}) & 0.14 & 1.0 & 0.08 & 0.51 \\
Abnormality of higher mental function ({\tt HP:0011446}) & 0.12 & 1.0 & 0.06 & 0.6 \\
Atrophy/Degeneration affecting the central nervous system ({\tt HP:0007367}) & 0.11 & 0.5 & 0.06 & 0.69 \\
Hypoplasia of the corpus callosum ({\tt HP:0002079}) & 0.11 & 0.5 & 0.06 & 1.0 \\
Areflexia ({\tt HP:0001284}) & 0.11 & 0.5 & 0.06 & 0.89 \\
Ventriculomegaly ({\tt HP:0002119}) & 0.11 & 0.5 & 0.06 & 0.81 \\
Abnormality of the cerebral ventricles ({\tt HP:0002118}) & 0.11 & 0.5 & 0.06 & 0.69 \\
Cerebral white matter hypoplasia ({\tt HP:0012430}) & 0.11 & 0.5 & 0.06 & 1.0 \\
Abnormality of eye movement ({\tt HP:0000496}) & 0.11 & 0.5 & 0.06 & 0.53 \\
\end{tabular}
PMID:27040691-Bhoj-2016-TBCK: Scoring completed. Candidates: 103
\begin{tabular}
{\bf Class} & {\bf r-score} & {\bf Inclusion} & & {\bf Exclusion} & {\bf IC} \\
\hline \hline
Cognitive impairment ({\tt HP:0100543}) & 0.6 & 0.8 & 0.47 & 0.77 \\
Intellectual disability ({\tt HP:0001249}) & 0.6 & 0.8 & 0.47 & 0.85 \\
Abnormality of higher mental function ({\tt HP:0011446}) & 0.47 & 1.0 & 0.31 & 0.6 \\
Severe global developmental delay ({\tt HP:0011344}) & 0.47 & 0.7 & 0.35 & 1.0 \\
Delayed speech and language development ({\tt HP:0000750}) & 0.37 & 0.7 & 0.25 & 0.83 \\
Abnormality of the curvature of the vertebral column ({\tt HP:0010674}) & 0.37 & 0.3 & 0.47 & 0.79 \\
Abnormality of the nasal tip ({\tt HP:0000436}) & 0.37 & 0.3 & 0.47 & 0.79 \\
Bulbous nose ({\tt HP:0000414}) & 0.37 & 0.3 & 0.47 & 1.0 \\
Increased head circumference ({\tt HP:0040194}) & 0.37 & 0.3 & 0.47 & 0.89 \\
Scoliosis ({\tt HP:0002650}) & 0.37 & 0.3 & 0.47 & 0.85 \\
Macrocephaly ({\tt HP:0000256}) & 0.37 & 0.3 & 0.47 & 0.89 \\
Abnormality of skeletal maturation ({\tt HP:0000927}) & 0.28 & 0.2 & 0.47 & 0.89 \\
Abnormality of skeletal physiology ({\tt HP:0011843}) & 0.28 & 0.2 & 0.47 & 0.7 \\
Delayed skeletal maturation ({\tt HP:0002750}) & 0.28 & 0.2 & 0.47 & 0.95 \\
Abnormal endocrine physiology ({\tt HP:0031072}) & 0.28 & 0.2 & 0.47 & 0.8 \\
Neurological speech impairment ({\tt HP:0002167}) & 0.27 & 0.5 & 0.19 & 0.72 \\
Absent speech ({\tt HP:0001344}) & 0.27 & 0.5 & 0.19 & 1.0 \\
Atrophy/Degeneration affecting the cerebrum ({\tt HP:0007369}) & 0.26 & 0.3 & 0.22 & 0.78 \\
Abnormality of the vertebral column ({\tt HP:0000925}) & 0.26 & 0.3 & 0.22 & 0.46 \\
Generalized hypotonia ({\tt HP:0001290}) & 0.26 & 0.3 & 0.22 & 0.95 \\
Cerebral atrophy ({\tt HP:0002059}) & 0.26 & 0.3 & 0.22 & 0.82 \\
Brain very small ({\tt HP:0001322}) & 0.26 & 0.3 & 0.22 & 0.76 \\
Brain atrophy ({\tt HP:0012444}) & 0.26 & 0.3 & 0.22 & 0.76 \\
Abnormal eyelid morphology ({\tt HP:0000492}) & 0.26 & 0.3 & 0.22 & 0.56 \\
Atrophy/Degeneration affecting the central nervous system ({\tt HP:0007367}) & 0.21 & 0.4 & 0.14 & 0.69 \\
Developmental regression ({\tt HP:0002376}) & 0.19 & 0.7 & 0.11 & 1.0 \\
Abnormality of the pituitary gland ({\tt HP:0012503}) & 0.17 & 0.1 & 0.47 & 0.65 \\
Long eyelashes ({\tt HP:0000527}) & 0.17 & 0.1 & 0.47 & 0.92 \\
Broad toe ({\tt HP:0001837}) & 0.17 & 0.1 & 0.47 & 0.87 \\
Abnormality of thyroid physiology ({\tt HP:0002926}) & 0.17 & 0.1 & 0.47 & 0.7 \\
Abnormality of the hypothalamus-pituitary axis ({\tt HP:0000864}) & 0.17 & 0.1 & 0.47 & 0.64 \\
Abnormality of the anterior pituitary ({\tt HP:0011747}) & 0.17 & 0.1 & 0.47 & 0.69 \\
Impairment in personality functioning ({\tt HP:0031466}) & 0.17 & 0.1 & 0.47 & 0.72 \\
Wide nasal bridge ({\tt HP:0000431}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Abnormality of the palpebral fissures ({\tt HP:0008050}) & 0.17 & 0.1 & 0.47 & 0.81 \\
Broad finger ({\tt HP:0001500}) & 0.17 & 0.1 & 0.47 & 0.73 \\
Abnormal inflammatory response ({\tt HP:0012647}) & 0.17 & 0.1 & 0.47 & 0.52 \\
Hypopituitarism ({\tt HP:0040075}) & 0.17 & 0.1 & 0.47 & 0.83 \\
Increased inflammatory response ({\tt HP:0012649}) & 0.17 & 0.1 & 0.47 & 0.52 \\
Abnormality of the chin ({\tt HP:0000306}) & 0.17 & 0.1 & 0.47 & 0.78 \\
Synophrys ({\tt HP:0000664}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Mandibular prognathia ({\tt HP:0000303}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Bipolar affective disorder ({\tt HP:0007302}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Asthma ({\tt HP:0002099}) & 0.17 & 0.1 & 0.47 & 0.92 \\
Immunologic hypersensitivity ({\tt HP:0100326}) & 0.17 & 0.1 & 0.47 & 0.8 \\
Abnormality of the adrenal glands ({\tt HP:0000834}) & 0.17 & 0.1 & 0.47 & 0.69 \\
Hyperthyroidism ({\tt HP:0000836}) & 0.17 & 0.1 & 0.47 & 0.87 \\
Autism ({\tt HP:0000717}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Anterior hypopituitarism ({\tt HP:0000830}) & 0.17 & 0.1 & 0.47 & 0.83 \\
Abnormality of adrenal physiology ({\tt HP:0011733}) & 0.17 & 0.1 & 0.47 & 0.77 \\
Central adrenal insufficiency ({\tt HP:0011734}) & 0.17 & 0.1 & 0.47 & 0.89 \\
Eczema ({\tt HP:0000964}) & 0.17 & 0.1 & 0.47 & 0.92 \\
Adrenal insufficiency ({\tt HP:0000846}) & 0.17 & 0.1 & 0.47 & 0.85 \\
Abnormal jaw morphology ({\tt HP:0030791}) & 0.17 & 0.1 & 0.47 & 0.65 \\
Growth hormone deficiency ({\tt HP:0000824}) & 0.17 & 0.1 & 0.47 & 0.95 \\
Abnormality of immune system physiology ({\tt HP:0010978}) & 0.17 & 0.1 & 0.47 & 0.42 \\
Abnormality of the thyroid gland ({\tt HP:0000820}) & 0.17 & 0.1 & 0.47 & 0.62 \\
Abnormality of facial skeleton ({\tt HP:0011821}) & 0.17 & 0.1 & 0.47 & 0.58 \\
Periventricular leukomalacia ({\tt HP:0006970}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Corneal opacity ({\tt HP:0007957}) & 0.17 & 0.1 & 0.47 & 0.79 \\
Abnormality of circulating hormone level ({\tt HP:0003117}) & 0.17 & 0.1 & 0.47 & 0.59 \\
Hyporeflexia ({\tt HP:0001265}) & 0.17 & 0.1 & 0.47 & 0.89 \\
Small cerebral cortex ({\tt HP:0002472}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Leukoencephalopathy ({\tt HP:0002352}) & 0.17 & 0.1 & 0.47 & 0.83 \\
Abnormality of the palate ({\tt HP:0000174}) & 0.17 & 0.1 & 0.47 & 0.67 \\
Large forehead ({\tt HP:0002003}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Cerebral cortical atrophy ({\tt HP:0002120}) & 0.17 & 0.1 & 0.47 & 0.87 \\
Neurodegeneration ({\tt HP:0002180}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Mania ({\tt HP:0100754}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Abnormality of prenatal development or birth ({\tt HP:0001197}) & 0.17 & 0.1 & 0.47 & 0.53 \\
Oligohydramnios ({\tt HP:0001562}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Abnormality of the amniotic fluid ({\tt HP:0001560}) & 0.17 & 0.1 & 0.47 & 0.89 \\
Abnormality of skin physiology ({\tt HP:0011122}) & 0.17 & 0.1 & 0.47 & 0.64 \\
Inflammatory abnormality of the skin ({\tt HP:0011123}) & 0.17 & 0.1 & 0.47 & 0.66 \\
Hearing impairment ({\tt HP:0000365}) & 0.17 & 0.1 & 0.47 & 0.68 \\
Hearing abnormality ({\tt HP:0000364}) & 0.17 & 0.1 & 0.47 & 0.67 \\
Abnormal cornea morphology ({\tt HP:0000481}) & 0.17 & 0.1 & 0.47 & 0.59 \\
Abnormality of the periventricular white matter ({\tt HP:0002518}) & 0.17 & 0.1 & 0.47 & 0.92 \\
Broad forehead ({\tt HP:0000337}) & 0.17 & 0.1 & 0.47 & 1.0 \\
High palate ({\tt HP:0000218}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Thick eyebrow ({\tt HP:0000574}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Mild global developmental delay ({\tt HP:0011342}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Decreased fetal movement ({\tt HP:0001558}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Slanting of the palpebral fissure ({\tt HP:0200006}) & 0.17 & 0.1 & 0.47 & 0.95 \\
Upslanted palpebral fissure ({\tt HP:0000582}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Prenatal movement abnormality ({\tt HP:0001557}) & 0.17 & 0.1 & 0.47 & 0.95 \\
Areflexia of lower limbs ({\tt HP:0002522}) & 0.17 & 0.1 & 0.47 & 0.95 \\
Facial hypertrichosis ({\tt HP:0002219}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Abnormality of the mandible ({\tt HP:0000277}) & 0.17 & 0.1 & 0.47 & 0.71 \\
Hirsutism ({\tt HP:0001007}) & 0.17 & 0.1 & 0.47 & 0.92 \\
Epicanthus ({\tt HP:0000286}) & 0.17 & 0.1 & 0.47 & 0.89 \\
Respiratory failure requiring assisted ventilation ({\tt HP:0004887}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Microcephaly ({\tt HP:0000252}) & 0.17 & 0.1 & 0.47 & 0.92 \\
Ventilator dependence with inability to wean ({\tt HP:0005946}) & 0.17 & 0.1 & 0.47 & 1.0 \\
Abnormality of the eyelashes ({\tt HP:0000499}) & 0.17 & 0.1 & 0.47 & 0.73 \\
Thick vermilion border ({\tt HP:0012471}) & 0.17 & 0.1 & 0.47 & 0.95 \\
Diffuse cerebellar atrophy ({\tt HP:0100275}) & 0.16 & 0.2 & 0.14 & 1.0 \\
Diffuse cerebral atrophy ({\tt HP:0002506}) & 0.16 & 0.2 & 0.14 & 1.0 \\
Abnormal ear physiology ({\tt HP:0031704}) & 0.16 & 0.2 & 0.14 & 0.67 \\
Cerebellar atrophy ({\tt HP:0001272}) & 0.16 & 0.2 & 0.14 & 0.85 \\
Global brain atrophy ({\tt HP:0002283}) & 0.16 & 0.2 & 0.14 & 1.0 \\
Abnormality of the ear ({\tt HP:0000598}) & 0.16 & 0.2 & 0.14 & 0.44 \\
Abnormal facial shape ({\tt HP:0001999}) & 0.16 & 0.5 & 0.1 & 0.71 \\
\end{tabular}
PMID:27275012-Guerreiro-2016-TBCK: Scoring completed. Candidates: 82
\begin{tabular}
{\bf Class} & {\bf r-score} & {\bf Inclusion} & & {\bf Exclusion} & {\bf IC} \\
\hline \hline
Early onset of sexual maturation ({\tt HP:0100000}) & 0.94 & 1.0 & 0.89 & 0.83 \\
Overlapping toe ({\tt HP:0001845}) & 0.94 & 1.0 & 0.89 & 1.0 \\
Deep palmar crease ({\tt HP:0006191}) & 0.94 & 1.0 & 0.89 & 1.0 \\
Puberty and gonadal disorders ({\tt HP:0008373}) & 0.94 & 1.0 & 0.89 & 0.64 \\
Single transverse palmar crease ({\tt HP:0000954}) & 0.94 & 1.0 & 0.89 & 1.0 \\
Abnormality of the skin of the palm ({\tt HP:0040211}) & 0.94 & 1.0 & 0.89 & 0.67 \\
Abnormal dermatoglyphics ({\tt HP:0007477}) & 0.94 & 1.0 & 0.89 & 0.72 \\
Precocious puberty ({\tt HP:0000826}) & 0.94 & 1.0 & 0.89 & 0.85 \\
Abnormality of the palm ({\tt HP:0100871}) & 0.94 & 1.0 & 0.89 & 0.65 \\
Infantile muscular hypotonia ({\tt HP:0008947}) & 0.94 & 1.0 & 0.89 & 1.0 \\
Regional abnormality of skin ({\tt HP:0011356}) & 0.94 & 1.0 & 0.89 & 0.6 \\
Abnormality of the palmar creases ({\tt HP:0010490}) & 0.94 & 1.0 & 0.89 & 0.82 \\
Abnormal palmar dermatoglyphics ({\tt HP:0001018}) & 0.94 & 1.0 & 0.89 & 0.74 \\
Generalized tonic-clonic seizures ({\tt HP:0002069}) & 0.72 & 1.0 & 0.56 & 0.89 \\
Abnormal hand morphology ({\tt HP:0005922}) & 0.72 & 1.0 & 0.56 & 0.63 \\
Abnormality of the knee ({\tt HP:0002815}) & 0.64 & 0.5 & 0.89 & 0.7 \\
Contractures of the joints of the upper limbs ({\tt HP:0100360}) & 0.64 & 0.5 & 0.89 & 0.7 \\
Abnormality of lower limb joint ({\tt HP:0100491}) & 0.64 & 0.5 & 0.89 & 0.56 \\
Abnormality of the breast ({\tt HP:0000769}) & 0.64 & 0.5 & 0.89 & 0.71 \\
Abnormal tendon morphology ({\tt HP:0100261}) & 0.64 & 0.5 & 0.89 & 0.59 \\
Elbow flexion contracture ({\tt HP:0002987}) & 0.64 & 0.5 & 0.89 & 1.0 \\
Skin tags ({\tt HP:0010609}) & 0.64 & 0.5 & 0.89 & 1.0 \\
Inverted nipples ({\tt HP:0003186}) & 0.64 & 0.5 & 0.89 & 1.0 \\
Knee flexion contracture ({\tt HP:0006380}) & 0.64 & 0.5 & 0.89 & 1.0 \\
Abnormality of joint mobility ({\tt HP:0011729}) & 0.64 & 0.5 & 0.89 & 0.48 \\
Contractures of the joints of the lower limbs ({\tt HP:0005750}) & 0.64 & 0.5 & 0.89 & 0.7 \\
Abnormality of the elbow ({\tt HP:0009811}) & 0.64 & 0.5 & 0.89 & 0.67 \\
Abnormality of upper limb joint ({\tt HP:0009810}) & 0.64 & 0.5 & 0.89 & 0.51 \\
Cardiorespiratory arrest ({\tt HP:0006543}) & 0.64 & 0.5 & 0.89 & 1.0 \\
Limb joint contracture ({\tt HP:0003121}) & 0.64 & 0.5 & 0.89 & 0.62 \\
Abnormality of the wrist ({\tt HP:0003019}) & 0.64 & 0.5 & 0.89 & 0.62 \\
Myoclonus ({\tt HP:0001336}) & 0.64 & 0.5 & 0.89 & 0.8 \\
Limited elbow movement ({\tt HP:0002996}) & 0.64 & 0.5 & 0.89 & 0.87 \\
Myoclonic spasms ({\tt HP:0003739}) & 0.64 & 0.5 & 0.89 & 1.0 \\
Abnormal joint morphology ({\tt HP:0001367}) & 0.64 & 0.5 & 0.89 & 0.4 \\
Limitation of joint mobility ({\tt HP:0001376}) & 0.64 & 0.5 & 0.89 & 0.67 \\
Abnormal nipple morphology ({\tt HP:0004404}) & 0.64 & 0.5 & 0.89 & 0.81 \\
Flexion contracture ({\tt HP:0001371}) & 0.64 & 0.5 & 0.89 & 0.6 \\
Respiratory arrest ({\tt HP:0005943}) & 0.64 & 0.5 & 0.89 & 1.0 \\
Abnormal breast morphology ({\tt HP:0031093}) & 0.64 & 0.5 & 0.89 & 0.72 \\
Wrist flexion contracture ({\tt HP:0001239}) & 0.64 & 0.5 & 0.89 & 0.95 \\
Preauricular skin tag ({\tt HP:0000384}) & 0.64 & 0.5 & 0.89 & 1.0 \\
Proptosis ({\tt HP:0000520}) & 0.57 & 1.0 & 0.39 & 1.0 \\
Generalized seizures ({\tt HP:0002197}) & 0.57 & 1.0 & 0.39 & 0.77 \\
Abnormality of the endocrine system ({\tt HP:0000818}) & 0.57 & 1.0 & 0.39 & 0.42 \\
Brachycephaly ({\tt HP:0000248}) & 0.57 & 1.0 & 0.39 & 0.95 \\
Decreased head circumference ({\tt HP:0040195}) & 0.46 & 1.0 & 0.29 & 0.89 \\
Abnormal conjugate eye movement ({\tt HP:0000549}) & 0.46 & 1.0 & 0.29 & 0.63 \\
Strabismus ({\tt HP:0000486}) & 0.46 & 1.0 & 0.29 & 0.64 \\
Abnormality of calvarial morphology ({\tt HP:0002648}) & 0.46 & 1.0 & 0.29 & 0.67 \\
Abnormality of the calvaria ({\tt HP:0002683}) & 0.46 & 1.0 & 0.29 & 0.59 \\
Nystagmus ({\tt HP:0000639}) & 0.44 & 0.5 & 0.39 & 0.76 \\
Abnormality of the thorax ({\tt HP:0000765}) & 0.44 & 0.5 & 0.39 & 0.52 \\
Abnormal involuntary eye movements ({\tt HP:0012547}) & 0.44 & 0.5 & 0.39 & 0.73 \\
Abnormality of the midface ({\tt HP:0000309}) & 0.44 & 0.5 & 0.39 & 0.71 \\
Vestibular dysfunction ({\tt HP:0001751}) & 0.44 & 0.5 & 0.39 & 0.89 \\
Abnormal vestibulo-ocular reflex ({\tt HP:0007670}) & 0.44 & 0.5 & 0.39 & 0.95 \\
Abnormal ear morphology ({\tt HP:0031703}) & 0.44 & 0.5 & 0.39 & 0.45 \\
Abnormality of the cheek ({\tt HP:0004426}) & 0.44 & 0.5 & 0.39 & 0.74 \\
Abnormality of the inner ear ({\tt HP:0000359}) & 0.44 & 0.5 & 0.39 & 0.61 \\
Muscle weakness ({\tt HP:0001324}) & 0.44 & 0.5 & 0.39 & 0.63 \\
Poor head control ({\tt HP:0002421}) & 0.44 & 0.5 & 0.39 & 1.0 \\
Localized skin lesion ({\tt HP:0011355}) & 0.44 & 0.5 & 0.39 & 0.51 \\
Abnormality of connective tissue ({\tt HP:0003549}) & 0.44 & 0.5 & 0.39 & 0.5 \\
Functional abnormality of the inner ear ({\tt HP:0011389}) & 0.44 & 0.5 & 0.39 & 0.73 \\
Abnormality of periauricular region ({\tt HP:0000383}) & 0.44 & 0.5 & 0.39 & 0.82 \\
Abnormality of central nervous system electrophysiology ({\tt HP:0030178}) & 0.37 & 1.0 & 0.23 & 0.56 \\
EEG abnormality ({\tt HP:0002353}) & 0.37 & 1.0 & 0.23 & 0.58 \\
Abnormal nervous system electrophysiology ({\tt HP:0001311}) & 0.37 & 1.0 & 0.23 & 0.56 \\
Abnormality of eye movement ({\tt HP:0000496}) & 0.37 & 1.0 & 0.23 & 0.53 \\
Abnormality of bony orbit of skull ({\tt HP:3000030}) & 0.31 & 0.5 & 0.23 & 0.95 \\
Focal seizures ({\tt HP:0007359}) & 0.31 & 0.5 & 0.23 & 0.69 \\
Abnormal ear physiology ({\tt HP:0031704}) & 0.31 & 0.5 & 0.23 & 0.67 \\
Involuntary movements ({\tt HP:0004305}) & 0.31 & 0.5 & 0.23 & 0.64 \\
Abnormality of the ear ({\tt HP:0000598}) & 0.31 & 0.5 & 0.23 & 0.44 \\
Shallow orbits ({\tt HP:0000586}) & 0.31 & 0.5 & 0.23 & 1.0 \\
Abnormality of globe location ({\tt HP:0100886}) & 0.25 & 1.0 & 0.14 & 0.85 \\
Abnormality of skull size ({\tt HP:0000240}) & 0.25 & 1.0 & 0.14 & 0.82 \\
Abnormality of movement ({\tt HP:0100022}) & 0.22 & 0.5 & 0.14 & 0.54 \\
Generalized hypotonia ({\tt HP:0001290}) & 0.22 & 0.5 & 0.14 & 0.95 \\
Abnormality of the skull ({\tt HP:0000929}) & 0.17 & 1.0 & 0.09 & 0.47 \\
Behavioral abnormality ({\tt HP:0000708}) & 0.14 & 1.0 & 0.08 & 0.52 \\
\end{tabular}
\begin{tabular}{p{5cm}|l|l|l|l}
{\bf PMID:27040692-Chong-2016-TBCK (5 members)} & {\bf r-score} & {\bf Inclusion} & {\bf Exclusion} & {\bf IC} \\
\hline \hline
Profound global developmental delay ({\tt HP:0012736}) & 0.85 & 1.0 & 0.74 & 1.0 \\
Prominent nasal bridge ({\tt HP:0000426}) & 0.85 & 1.0 & 0.74 & 1.0 \\
Abnormality of the nasal alae ({\tt HP:0000429}) & 0.85 & 1.0 & 0.74 & 0.82 \\
Abnormality of the nares ({\tt HP:0005288}) & 0.85 & 1.0 & 0.74 & 0.82 \\
Feeding difficulties ({\tt HP:0011968}) & 0.85 & 1.0 & 0.74 & 0.83 \\
Exaggerated cupid's bow ({\tt HP:0002263}) & 0.85 & 1.0 & 0.74 & 1.0 \\
Cerebellar vermis hypoplasia ({\tt HP:0001320}) & 0.85 & 1.0 & 0.74 & 0.95 \\
Small forehead ({\tt HP:0000350}) & 0.85 & 1.0 & 0.74 & 1.0 \\
Small basal ganglia ({\tt HP:0012697}) & 0.85 & 1.0 & 0.74 & 1.0 \\
Narrow forehead ({\tt HP:0000341}) & 0.85 & 1.0 & 0.74 & 1.0 \\
Anteverted nares ({\tt HP:0000463}) & 0.85 & 1.0 & 0.74 & 0.95 \\
Aplasia/Hypoplasia of the cerebellar vermis ({\tt HP:0006817}) & 0.85 & 1.0 & 0.74 & 0.87 \\
Abnormality of the cerebellar vermis ({\tt HP:0002334}) & 0.85 & 1.0 & 0.74 & 0.8 \\
Cerebellar malformation ({\tt HP:0002438}) & 0.85 & 1.0 & 0.74 & 0.74 \\
Highly arched eyebrow ({\tt HP:0002553}) & 0.85 & 1.0 & 0.74 & 1.0 \\
\hline
{\em Overall} & - & {\em 100.0 } & - & - \\ 
\end{tabular}
\begin{tabular}{p{5cm}|l|l|l|l}
{\bf PMID:30103036-Zapata-Aldana-2019-TBCK (2 members)} & {\bf r-score} & {\bf Inclusion} & {\bf Exclusion} & {\bf IC} \\
\hline \hline
Impaired social interactions ({\tt HP:0000735}) & 0.94 & 1.0 & 0.89 & 0.87 \\
Poor eye contact ({\tt HP:0000817}) & 0.94 & 1.0 & 0.89 & 1.0 \\
Respiratory failure ({\tt HP:0002878}) & 0.94 & 1.0 & 0.89 & 1.0 \\
Abnormal social behavior ({\tt HP:0012433}) & 0.94 & 1.0 & 0.89 & 0.81 \\
Long philtrum ({\tt HP:0000343}) & 0.94 & 1.0 & 0.89 & 1.0 \\
Abnormality of the philtrum ({\tt HP:0000288}) & 0.94 & 1.0 & 0.89 & 0.79 \\
\hline
{\em Overall} & - & {\em 100.0 } & - & - \\ 
\end{tabular}
\begin{tabular}{p{5cm}|l|l|l|l}
{\bf PMID:27040691-Bhoj-2016-TBCK (10 members)} & {\bf r-score} & {\bf Inclusion} & {\bf Exclusion} & {\bf IC} \\
\hline \hline
Cognitive impairment ({\tt HP:0100543}) & 0.6 & 0.8 & 0.47 & 0.77 \\
Intellectual disability ({\tt HP:0001249}) & 0.6 & 0.8 & 0.47 & 0.85 \\
Severe global developmental delay ({\tt HP:0011344}) & 0.47 & 0.7 & 0.35 & 1.0 \\
\hline
{\em Overall} & - & {\em 100.0 } & - & - \\ 
\end{tabular}
\begin{tabular}{p{5cm}|l|l|l|l}
{\bf PMID:27275012-Guerreiro-2016-TBCK (2 members)} & {\bf r-score} & {\bf Inclusion} & {\bf Exclusion} & {\bf IC} \\
\hline \hline
Early onset of sexual maturation ({\tt HP:0100000}) & 0.94 & 1.0 & 0.89 & 0.83 \\
Overlapping toe ({\tt HP:0001845}) & 0.94 & 1.0 & 0.89 & 1.0 \\
Deep palmar crease ({\tt HP:0006191}) & 0.94 & 1.0 & 0.89 & 1.0 \\
Single transverse palmar crease ({\tt HP:0000954}) & 0.94 & 1.0 & 0.89 & 1.0 \\
Abnormal dermatoglyphics ({\tt HP:0007477}) & 0.94 & 1.0 & 0.89 & 0.72 \\
Precocious puberty ({\tt HP:0000826}) & 0.94 & 1.0 & 0.89 & 0.85 \\
Infantile muscular hypotonia ({\tt HP:0008947}) & 0.94 & 1.0 & 0.89 & 1.0 \\
Abnormality of the palmar creases ({\tt HP:0010490}) & 0.94 & 1.0 & 0.89 & 0.82 \\
Abnormal palmar dermatoglyphics ({\tt HP:0001018}) & 0.94 & 1.0 & 0.89 & 0.74 \\
\hline
{\em Overall} & - & {\em 100.0 } & - & - \\ 
\end{tabular}
Classifying 'PMID:27040692-Chong-2016-TBCK' using candidate set with OI: 100
Classifying 'PMID:30103036-Zapata-Aldana-2019-TBCK' using candidate set with OI: 100
Classifying 'PMID:27040691-Bhoj-2016-TBCK' using candidate set with OI: 100
Classifying 'PMID:27275012-Guerreiro-2016-TBCK' using candidate set with OI: 100
Reclassification:
PMID:27040692-Chong-2016-TBCK AUC: 1.0
PMID:30103036-Zapata-Aldana-2019-TBCK AUC: 1.0
PMID:27040691-Bhoj-2016-TBCK AUC: 0.9888888888888889
PMID:27275012-Guerreiro-2016-TBCK AUC: 1.0

